Delveinsight

OCTOBER 1, 2021

This disease is associated with antibodies directed against the acetylcholine receptor, muscle-specific kinase (MUSK), lipoprotein-related protein 4 (LRP4), or agrin in the postsynaptic membrane at the neuromuscular junction. The current Myasthenia Gravis therapeutics market has many FDA-approved drugs for the treatment of Myasthenia Gravis.

Marketing 85

Marketing Antibody Drugs Sales 85

Delveinsight

JULY 26, 2021

However, antibiotics are the only available treatment options in the Uncomplicated Urinary Tract Infections market to cater to such a large patient pool. Some of the most commonly prescribed antibiotics in the Uncomplicated Urinary Tract Infection therapy market include the combination drug trimethoprim and sulfamethoxazole, trimethoprim, ?-lactams,

Marketing 93

Marketing Bacteria Vaccination Vaccine 93

XTalks

JUNE 21, 2022

We’ve teamed up with @marsglobal , to create #CO2COA , a sustainable, animal-free chocolate made with rich, silky smooth Rainforest Alliance-Certified cocoa and our animal-free dairy protein. CO2COA is considered vegan-friendly since it doesn’t contain ingredients from animals, but it is also lactose- and cholesterol-free.

Protein 98

Protein Branding Packaging Packaging 98

XTalks

MARCH 13, 2024

The products contain ingredients like bamboo fiber, pea protein and mushrooms. Despite the enthusiasm, the introduction of these vegan hot dogs comes at a challenging time for sausage alternatives, which, like many alt-meat products, have seen a decline in retail sales. billion in 2023 to $19 billion by 2030.

Branding 59

Branding Sales Production Marketing 59

XTalks

OCTOBER 25, 2023

A Los Angeles startup, Sunnie, has unveiled its version of healthy Lunchables, providing a refreshing and nutritious twist on the nearly four-decade-old Lunchables brand, which reported sales of $1.8 They embarked on this venture after realizing a void in the children’s snacking market for wholesome options. billion last year.

Containment 59

Containment Production Branding Protein 59

XTalks

OCTOBER 28, 2022

From collagen water to protein chips to a plastic straw alternative, the exhibitors did not disappoint the more than 300,000 attendees from around the world. . Making up 80 percent of the ligaments, cartilage and tissues of our skin, collagen is the most abundant protein in the human body. Protein Chips. Collagen Water.

Protein 52

Protein Marketing Packaging Packaging 52

The Pharma Data

DECEMBER 16, 2020

Evotec and Bristol Myers Squibb (the successor in interest to Celgene ) initiated their long-term strategic drug discovery and development partnership in the field of targeted protein degradation in 2018 with the goal to identify novel drug targets. For additional information please go to www.evotec.com and follow us on Twitter @Evotec.

Protein 40

Protein Containment Bioinformatics Drugs 40

XTalks

SEPTEMBER 25, 2020

Each soup contains protein sourced from plant-based products. Each serving has 10 to 15 grams of protein. “With plant-based foods gaining broader acceptance, and with so many popular soups featuring meat on the market, extending Gardein into the soups category was a logical next step for the brand.”

Branding 76

Branding Sales Protein Containment 76

Pharmaceutical Technology

AUGUST 22, 2022

Softgel capsules, containing a liquid, paste or emulsion active ingredient, are trusted and favoured by many patients. Softgels have now achieved strong recognition in the prescription, consumer health and supplements markets. They also offer enhanced bioavailability, exact dosing and an extended shelf life.

Compliance 130

Compliance Bioavailability Containment Branding 130

XTalks

OCTOBER 4, 2022

The products were formulated with pea and rice protein fermented by shiitake mushrooms. With several competitors in the crowded space, the Ozo brand attempted to stand out by making its first products soy-free and contain less saturated fat and fewer calories than its rivals. billion in 2021 and estimated that it will reach $15.8

Branding 98

Branding Sales Manufacturing Production 98

XTalks

JULY 23, 2021

The fitness and nutrition industry uses macadamia nuts to make protein powder, and this nut oil can also be used to make capsules for dietary supplements. Most sales that Strength Genesis has been able to target are towards health enthusiasts and foodies. In 2019 , the macadamia nut market was valued at $1.17

Containment 105

Containment Packaging Packaging Marketing 105

XTalks

DECEMBER 1, 2020

billion (€1 billion) in sales from plant-based meat and dairy products in the next five to seven years. Some revenue may also come from the sale of Burger King’s plant-based Whopper and nuggets in Europe, Africa and parts of Asia, as the brand was chosen as Burger King’s supplier last year.

Branding 89

Branding Sales Production Packaging 89

The Pharma Data

DECEMBER 15, 2020

Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation using its PROTAC ® Discovery Engine, today announced the pricing of an underwritten public offering of 5,714,286 shares of its common stock at a price of $70.00 NEW HAVEN, Conn., Goldman Sachs & Co. About Arvinas, Inc.

Containment 52

Containment Protein Engineer Sales 52

XTalks

AUGUST 25, 2021

Walnuts contain a number of essential nutrients, including protein, fiber, and magnesium and have a decent amount of omega 3 fatty acids. In July 2021 , it was reported that the walnut market is expected to see significant growth and increasing demand from end-users in the industry. In 2020 the walnut market accounted for $5.3

Nurses 97

Nurses Containment Research Protein 97

XTalks

MAY 1, 2023

Qalsody contains tofersen, an antisense oligonucleotide that specifically targets the mRNA made from mutated SODI genes to prevent the formation of toxic SOD1 proteins. At its peak sales, Qalsody is expected to generate around $300 million for Biogen. How Does Qalsody Work?

FDA Approval 89

FDA Approval Gene Genetics Protein 89

XTalks

FEBRUARY 2, 2021

Products in this category are typically made from a mix of plant-based and animal-based proteins, reducing the reliance on solely animals and increasing the amount of product that can be sold. Some believe that the motivation to market hybrids comes from the need to ship more products rather than to meet consumer needs.

Production 75

Production Protein Containment Sales 75

The Pharma Data

JANUARY 17, 2021

The treatment is based on the Grifols immunoglobulin Gamunex®-C, and contains anti-SARS-COV-2 polyclonal antibodies from plasma donors who have recovered from COVID-19. It could also help contain outbreaks in places where the vaccination hasn’t begun or is still underway. BARCELONA, Spain , Jan. and on the U.S.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Containment 52

Delveinsight

DECEMBER 7, 2020

Unlike most other industries, in MedTech, AI is not confined to sales and operations ends of the value chain. Banyan Biomarkers is one company to be able to market a blood-based diagnostic test in the US market, as it utilizes tech to aid the detection of traumatic brain injuries and concussions.

Protein 56

Protein Insulin Hormones FDA Approval 56

XTalks

MARCH 16, 2021

Kind Frozen Smoothie Bowls contain fruits and an almond milk base with creamy nut butter and crunchy granola. The bowls include 9g of added sugar, 7g of protein, and are ready-to-eat straight from the freezer. Kind’s sales reached $1.5 According to Mordor Intelligence , the global smoothie market is growing at a CAGR of 7.2

Production 64

Production Containment Branding Protein 64

pharmaphorum

SEPTEMBER 18, 2020

German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

The Pharma Data

JULY 27, 2021

Versatile antibody variable domains (UniDab®) derived from UniAb® can be assembled into multi-specific and multivalent therapeutic proteins, surpassing limitations of conventional antibody therapeutics. No forward-looking statement can be guaranteed and actual results may differ materially from those we project.

Production 52

Production Antibody Sales Manufacturing 52

Drug Discovery World

OCTOBER 20, 2022

Japan continues to be one of the largest pharmaceutical markets in the world, despite what the International Trade Administration described as ‘a challenging business landscape due to demographics’ 1. According to the International Trade Administration’s market overview, anti-tumour agents brought in the largest sales in 2020 in Japan.

Development 52

Development Drugs Life Science Marketing 52

The Pharma Data

DECEMBER 8, 2020

Jefferies, Stifel, Guggenheim Securities and RBC Capital Markets are acting as joint book-running managers for the offering. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. About IGM Biosciences, Inc.

Antibody 52

Antibody Engineer Containment Sales 52

pharmaphorum

AUGUST 16, 2020

It is based on an adenoviral vector formed on a weakened version of the adenovirus that causes a common cold-line illness in chimpanzees, containing the genetic material of SARS-CoV-2 spike protein.

Vaccination 111

Vaccination Vaccine Immune Response Trials 111

Drug Discovery World

MARCH 7, 2023

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare. The Middle East represents one of the world’s most lucrative markets for pharmaceuticals.

Biobanking 52

Biobanking Drugs Genome Genomics 52

The Pharma Data

NOVEMBER 4, 2020

As part of the License Agreement, Crescita will receive an upfront payment in cash of US$125,000 and will be eligible for regulatory and sales milestones of up to US$1.0 The formulation contains a eutectic mixture of 7% lidocaine and 7% tetracaine that utilizes the Company’s proprietary phase-changing topical cream Peel technology.

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

JANUARY 6, 2021

.” Based on the collaboration agreement, CureVac will be the Marketing Authorization Holder for the product, while Bayer will support CureVac with country operations within the European Union (EU) and selected additional markets. In fiscal 2019, the Group employed around 104,000 people and had sales of 43.5 billion euros.

Vaccination 52

Vaccination Vaccine Development Marketing 52

XTalks

FEBRUARY 20, 2024

Take a closer look at how the vaccines compare with respect to their efficacy, side effects and market performance so far. Type of Vaccine Arexvy and Abrysvo are both recombinant protein subunit vaccines. Another difference is that Arexvy contains an adjuvant while Abrysvo does not. billion or £1.2

Vaccination 105

Vaccination Vaccine Containment Marketing 105

The Pharma Data

AUGUST 17, 2020

DF6002 is a monovalent IL-12 immunoglobulin Fc fusion protein proposed to achieve strong anti-tumor efficacy by establishing an inflammatory tumor microenvironment necessary for productive anti-tumor responses. In addition, Dragonfly will receive up to 24% royalties on worldwide net sales. Dragonfly received U.S.

Licensing 52

Licensing Licensing Development Production 52

Pharmaceutical Technology

JUNE 21, 2023

In the past year, Hemgenix has been granted approval by the US Food and Drug Administration (FDA) and has received conditional marketing authorisation from the European Commission (EC) and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This followed positive results from CSL’s Phase III HOPE-B trial (NCT03569891).

Gene Therapy 246

Gene Therapy Gene Protein Sales 246

The Pharma Data

DECEMBER 14, 2020

The global GBM treatment market is projected to reach $3.3 representing the largest market. The effectiveness of standard therapy with TMZ is limited because the response of GBM to TMZ is dependent upon the expression of the DNA repair enzymatic protein, O 6 -alkylguanine DNA alkyltransferase (MGMT).

Drugs 52

Drugs Genome Genomics DNA 52

The Pharma Data

AUGUST 3, 2021

. – Second-quarter 2021 operating expenses increased 18 percent, driven primarily by higher research and development investments for late-stage assets, as well as higher relative marketing and selling expenses due to pandemic-related spending reductions in 2020. million of revenue from sales of COVID-19 antibodies.

Antibody 52

Antibody Sales Production Development 52

The Pharma Data

NOVEMBER 20, 2020

Zokinvy blocks the accumulation of defective, farnesylated proteins which form tight associations with the nuclear envelope, leading to cellular instability and the process of premature aging in children and young adults with Progeria and processing-deficient Progeroid Laminopathies. ABOUT ZOKINVY (LONAFARNIB). LIMITATIONS OF USE.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 10, 2020

The abstract, titled Gamma-secretase modulators show selectivity for gamma-secretase-mediated amyloid precursor protein intramembrane processing is written by Helena Karlström at Karolinska Institutet (Principal Investigator for the study) and Erik Portelius at the University of Gothenburg. The sticky A?42 [link].

Development 40

Development Drugs Protein Research 40

The Pharma Data

SEPTEMBER 17, 2020

The test targets antibodies against the spike protein. Basel, 18 September 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. This is the focus of vaccines in development and convalescent plasma therapy.

Antibody 52

Antibody Vaccination Vaccine In-Vitro 52

Delveinsight

DECEMBER 13, 2020

The first approved treatment for hepatitis C was a series of protein-based injections called recombinant interferon-alfa (IFNa). Interferons are naturally occurring proteins in the body; recombinant IFNa is the protein-based drug that works to mobilize the body’s natural immune system to fight disease. in January 2019.

Genotype 52

Genotype FDA Approval DNA Drugs 52

The Pharma Data

OCTOBER 21, 2020

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Gene Therapy 40

Gene Therapy Immune Response Sales Gene 40